Evidence map›Paper›PMID 37965542›Full record

ArticleFrontiers in microbiology2023

The absence of surface D-alanylation, localized on lipoteichoic acid, impacts the

Pierre-Alexandre Lacotte, Sandrine Denis-Quanquin, Eva Chatonnat, Julie Le Bris, David Leparfait, Thierry Lequeux, Isabelle Martin-Verstraete, Thomas Candela

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Frontiers in immunology · 2026
    Article
  3. D-Serine Can Modify the Wall Teichoic Acid of MRSA via theInternational journal of molecular sciences · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Pierre-Alexandre LacotteMicalis Institute, Université Paris-Saclay, INRAE AgroParisTech, Jouy-en-Josas, France.
Sandrine Denis-QuanquinLaboratoire de Chimie, UMR5182, ENS Lyon, CNRS, Université Lyon 1, Lyon, France.
Eva ChatonnatInstitut Pasteur, Université Paris Cité, UMR6047 CNRS, Laboratoire Pathogenèse des Bactéries Anaérobies, Paris, France.
Julie Le BrisMicrobial Evolutionary Genomics, Institut Pasteur, CNRS UMR3525, Université Paris Cité, Paris, France.
David LeparfaitNormandie Université, Laboratoire de Chimie Moléculaire et Thioorganique LCMT UMR6507, ENSICAEN, UNICAEN, CNRS, Caen, France.
Thierry LequeuxNormandie Université, Laboratoire de Chimie Moléculaire et Thioorganique LCMT UMR6507, ENSICAEN, UNICAEN, CNRS, Caen, France.
Isabelle Martin-VerstraeteInstitut Pasteur, Université Paris Cité, UMR6047 CNRS, Laboratoire Pathogenèse des Bactéries Anaérobies, Paris, France.
Thomas CandelaMicalis Institute, Université Paris-Saclay, INRAE AgroParisTech, Jouy-en-Josas, France.
Centre National de la Recherche Scientifique · FRUniversité Claude Bernard Lyon 1 · FRUniversité Paris-Saclay · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The Methods: We studied the D-alanylation of Results: We first confirmed the role of the Conclusion: Our results suggest the D-alanylation of

Indexed as

antibioticsCAMPscell wallD-alanylationlipoteichoic acidpolysaccharides

Identifiers

PMID37965542
PMCPMC10642750
OpenAlexW4388102341

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.